Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Finance Lease Liabilities (Total)

Finance Lease Liabilities (Total) at other companies

Rogers Corporation logo
Rogers CorporationROG
$8.3M-8.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$152K-61.6%
Alumis Inc. logo
Alumis Inc.ALMS
$0—
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$50K-31.5%

Segments

By geography

See full
Visp, Switzerland$64.7M-9.3%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's finance lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's finance lease liabilities (total)?
Aurinia Pharmaceuticals (AUPH) reported finance lease liabilities (total) of $64.7M in Q1 2026.
How has Aurinia Pharmaceuticals's finance lease liabilities (total) changed year-over-year?
Aurinia Pharmaceuticals's finance lease liabilities (total) decreased by 9.3% year-over-year, from $71.34M to $64.7M.
What is the long-term trend for Aurinia Pharmaceuticals's finance lease liabilities (total)?
Over 2 years (2023 to 2025), Aurinia Pharmaceuticals's finance lease liabilities (total) has grown at a -12.6% compound annual growth rate (CAGR), from $90.09M to $68.85M.
What does finance lease liabilities (total) mean?
Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.